Skip to main content

CORRECTION article

Front. Med., 10 July 2023
Sec. Gene and Cell Therapy
Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1244638

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

This article is a correction to:

  1. Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

    1. Read original article
\r\nHanwen Lu,&#x;Hanwen Lu1,2†Liwei Zhou,&#x;Liwei Zhou1,3†Bingchang Zhang,Bingchang Zhang1,3Yuanyuan Xie,Yuanyuan Xie1,3Huiyin Yang,Huiyin Yang1,2Zhanxiang Wang,, Zhanxiang Wang1,2,3*
  • 1Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
  • 2Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China
  • 3Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

A corrigendum on
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

by Lu, H., Zhou, L., Zhang, B., Xie, Y., Yang, H., and Wang, Z. (2022). Front. Med. 9:939776. doi: 10.3389/fmed.2022.939776

In the published article, there was an error in affiliation 1. Instead of “Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Xiamen, China”, it should be “Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China”.

In the published article, there was an error in affiliation 2. Instead of “Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China”, it should be “Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China”.

In the published article, there was an error in affiliation 3. Instead of “Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, Xiamen, China”, it should be “Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China”.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Cuproptosis, glioma, prognostic biomarker, immune infiltration, lipoylation

Citation: Lu H, Zhou L, Zhang B, Xie Y, Yang H and Wang Z (2023) Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma. Front. Med. 10:1244638. doi: 10.3389/fmed.2023.1244638

Received: 22 June 2023; Accepted: 23 June 2023;
Published: 10 July 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Lu, Zhou, Zhang, Xie, Yang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhanxiang Wang, V2FuZ1pYJiN4MDAwNDA7eG11LmVkdS5jbg==

†These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.